Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Mekophar Chemical Pharmaceutical JSC ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-1.73%
EBIT Growth (5y)
-184.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
194,901.75
Tax Ratio
36.50%
Dividend Payout Ratio
30.98%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.55%
ROE (avg)
11.43%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.26
EV to EBIT
-2.66
EV to EBITDA
-9.60
EV to Capital Employed
0.13
EV to Sales
0.14
PEG Ratio
NA
Dividend Yield
3.90%
ROCE (Latest)
-4.74%
ROE (Latest)
-0.83%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Bearish
No Trend
OBV
No Trend
Mildly Bearish
Technical Movement
1What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -13.75% (YoY
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Mekophar Chemical Pharmaceutical JSC
Raw Material Cost
Fallen by -13.75% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






